Howard Capital Management’s AbbVie ABBV Stock Holding History

Howard Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.24M	Buy	32,751 +25,411	+346%	+$5.47M	0.1%	71
2026 Q1	$1.6M	Sell	7,340 -25,668	-78%	-$5.69M	0.03%	143
2025 Q4	$7.54M	Buy	33,008 +1,849	+6%	+$421K	0.1%	61
2025 Q3	$7.21M	Buy	31,159 +3,093	+11%	+$630K	0.1%	57
2025 Q2	$5.21M	Buy	28,066 +7,160	+34%	+$1.33M	0.08%	74
2025 Q1	$4.38M	Sell	20,906 -412	-2%	-$80.1K	0.11%	71
2024 Q4	$3.79M	Buy	21,318 +2,324	+12%	+$427K	0.06%	97
2024 Q3	$3.75M	Buy	18,994 +14,482	+321%	+$2.7M	0.06%	93
2024 Q2	$774K	Buy	4,512 +2,613	+138%	+$433K	0.08%	54
2024 Q1	$346K	Buy	+1,899	New	+$327K	0.04%	64
2018 Q1	–	Sell	-86,762	Closed	-$8.39M	–	86
2017 Q4	$8.39M	Buy	+86,762	New	+$8.18M	1.34%	32

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Howard Capital Management's ABBV Position: Q2 2026 in Review

Howard Capital Management increased its AbbVie (ABBV) stake by 346% in Q2 2026, buying an estimated $5.47M and bringing the position to 32,751 shares worth $8.24M. The position accounts for 0.1% of the portfolio, ranked #71.

Howard Capital Management first reported a position in ABBV in Q4 2017 and has held it in 11 quarters since. The position peaked at $8.39M in Q4 2017. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Howard Capital Management held 32,751 shares of AbbVie worth $8.24M as of Q2 2026.
Howard Capital Management bought 25,411 AbbVie shares in Q2 2026, an estimated $5.47M.
AbbVie made up 0.1% of Howard Capital Management's portfolio in Q2 2026, its #71 holding.
Howard Capital Management first reported a position in AbbVie in Q4 2017 and has held it in 11 quarters since.
Howard Capital Management's AbbVie position peaked at $8.39M in Q4 2017.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Howard Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.